Literature DB >> 11933204

Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin.

Jinxiu Shi1, Lijian Hui, Yonghai Xu, Feng Wang, Wei Huang, Gengxi Hu.   

Abstract

Human mu-opioid receptor (OPRM1) is the major site for the analgesic action of most opioid drugs such as morphine, methadone and heroin. It was previously reported that a single nucleotide polymorphism (SNP) in exon1 (c.118A-->G) of OPRM1 might modestly alter the affinity in beta-endorphin-Mu interaction. Using denaturing high performance liquid chromatography (DHPLC) the complete coding region of the OPRM1 gene was screened for SNPs in Han-Chinese heroin addicts and normal control. Three novel SNPs were detected, one in exon3, one in intron3 and one in the 3' untranslated region. The SNP c.118A-->G reportedly altered the interaction of Mu receptor with opioid had no statistically significant correlation with heroin addition in Han Chinese. However, addicted subjects with the SNP in intron2 (IVS2 +31G-->A) tended to show much higher heroin intake dosages than those without this SNP. We also observed that individuals carrying both SNP c.118A-->G and IVS2 +31G-->A consumed relatively more drugs compared to other addicts. Thus our study further highlights the importance of studing the various regions of the mu opioid receptor gene, coding as well as non-coding, for genetic markers that may be linked to, or directly contribute to opioid drug-seeking behavior. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933204     DOI: 10.1002/humu.9026

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  43 in total

1.  No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample.

Authors:  Momchil A Nikolov; Olga Beltcheva; Antoaneta Galabova; Anna Ljubenova; Elena Jankova; Galin Gergov; Atanas A Russev; Michael T Lynskey; Elliot C Nelson; Eleonora Nesheva; Dorita Krasteva; Philip Lazarov; Vanio I Mitev; Ivo M Kremensky; Radka P Kaneva; Alexandre A Todorov
Journal:  Drug Alcohol Depend       Date:  2011-01-31       Impact factor: 4.492

Review 2.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

Review 3.  An overview of the genetics of substance use disorders.

Authors:  H M Lachman
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

4.  Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

Authors:  Huiping Zhang; Xingguang Luo; Henry R Kranzler; Jaakko Lappalainen; Bao-Zhu Yang; Evgeny Krupitsky; Edwin Zvartau; Joel Gelernter
Journal:  Hum Mol Genet       Date:  2006-02-13       Impact factor: 6.150

5.  Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis.

Authors:  Stephen J Glatt; Chad Bousman; Richard S Wang; Kenton K Murthy; Brinda K Rana; Jessica A Lasky-Su; Shao C Zhu; Ruimin Zhang; Jianhua Li; Bo Zhang; Jixiang Li; Michael J Lyons; Stephen V Faraone; Ming T Tsuang
Journal:  Drug Alcohol Depend       Date:  2007-04-09       Impact factor: 4.492

Review 6.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

Review 7.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

8.  A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.

Authors:  Jin Xu; Zhigang Lu; Mingming Xu; Ling Pan; Yi Deng; Xiaohu Xie; Huifen Liu; Shixiong Ding; Yasmin L Hurd; Gavril W Pasternak; Robert J Klein; Luca Cartegni; Wenhua Zhou; Ying-Xian Pan
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

9.  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.

Authors:  Eric A Woodcock; Leslie H Lundahl; Margit Burmeister; Mark K Greenwald
Journal:  Am J Addict       Date:  2015-04-24

Review 10.  OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.

Authors:  Stephen D Mague; Julie A Blendy
Journal:  Drug Alcohol Depend       Date:  2010-01-13       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.